Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Wiseman

Showing results (141-150 of 158) with videos related to

Pageof 16
Sort By:
British Journal of Haematology|May 26, 2018
Transcriptomic rationale for synthetic lethality-targeting ERCC1 and CDKN1A in chronic myelomonocytic leukaemiaAna M Hurtado, Gines Luengo-Gil, Tzu H Chen-Liang, et al.
Science Translational Medicine|March 1, 2023
Vitamin B5 and succinyl-CoA improve ineffective erythropoiesis in <i>SF3B1</i>-mutated myelodysplasiaSyed A Mian, Céline Philippe, Eleni Maniati, et al.
Nucleic Acids Research|August 14, 2018
Erratum: EVI1 carboxy-terminal phosphorylation is ATM-mediated and sustains transcriptional modulation and self-renewal via enhanced CtBP1 associationRoberto Paredes, Marion Schneider, Adam Stevens, et al.
Nucleic Acids Research|June 26, 2018
EVI1 carboxy-terminal phosphorylation is ATM-mediated and sustains transcriptional modulation and self-renewal via enhanced CtBP1 associationRoberto Paredes, Marion Schneider, Adam Stevens, et al.
Cancer Cell|November 23, 2023
Therapeutic targeting of EP300/CBP by bromodomain inhibition in hematologic malignanciesLuciano Nicosia, Gary J Spencer, Nigel Brooks, et al.
Blood Advances|May 17, 2024
The E592K variant of SF3B1 creates unique RNA missplicing and associates with high-risk MDS without ring sideroblastsIn Young Choi, Jonathan P Ling, Jian Zhang, et al.
Journal of Medicinal Chemistry|December 23, 2016
Discovery and Optimization of Allosteric Inhibitors of Mutant Isocitrate Dehydrogenase 1 (R132H IDH1) Displaying Activity in Human Acute Myeloid Leukemia CellsStuart Jones, Jonathan Ahmet, Kelly Ayton, et al.
Leukemia|October 4, 2024
Synergistic effect of concurrent high molecular risk mutations and lower JAK2 mutant variant allele frequencies on prognosis in patients with myelofibrosis-insights from a multicenter studyYu-Hung Wang, Chao-Hung Wei, Chien-Chin Lin, et al.
Nature|October 4, 2019
Coordinated alterations in RNA splicing and epigenetic regulation drive leukaemogenesisAkihide Yoshimi, Kuan-Ting Lin, Daniel H Wiseman, et al.
Cell Stem Cell|August 15, 2023
Single-cell multi-omics defines the cell-type-specific impact of splicing aberrations in human hematopoietic clonal outgrowthsMariela Cortés-López, Paulina Chamely, Allegra G Hawkins, et al.
Pageof 16

Showing results (141-150 of 158) with videos related to

Sort By:
Pageof 16
British Journal of Haematology|May 26, 2018
Transcriptomic rationale for synthetic lethality-targeting ERCC1 and CDKN1A in chronic myelomonocytic leukaemiaAna M Hurtado, Gines Luengo-Gil, Tzu H Chen-Liang, et al.
Science Translational Medicine|March 1, 2023
Vitamin B5 and succinyl-CoA improve ineffective erythropoiesis in <i>SF3B1</i>-mutated myelodysplasiaSyed A Mian, Céline Philippe, Eleni Maniati, et al.
Nucleic Acids Research|August 14, 2018
Erratum: EVI1 carboxy-terminal phosphorylation is ATM-mediated and sustains transcriptional modulation and self-renewal via enhanced CtBP1 associationRoberto Paredes, Marion Schneider, Adam Stevens, et al.
Nucleic Acids Research|June 26, 2018
EVI1 carboxy-terminal phosphorylation is ATM-mediated and sustains transcriptional modulation and self-renewal via enhanced CtBP1 associationRoberto Paredes, Marion Schneider, Adam Stevens, et al.
Cancer Cell|November 23, 2023
Therapeutic targeting of EP300/CBP by bromodomain inhibition in hematologic malignanciesLuciano Nicosia, Gary J Spencer, Nigel Brooks, et al.
Blood Advances|May 17, 2024
The E592K variant of SF3B1 creates unique RNA missplicing and associates with high-risk MDS without ring sideroblastsIn Young Choi, Jonathan P Ling, Jian Zhang, et al.
Journal of Medicinal Chemistry|December 23, 2016
Discovery and Optimization of Allosteric Inhibitors of Mutant Isocitrate Dehydrogenase 1 (R132H IDH1) Displaying Activity in Human Acute Myeloid Leukemia CellsStuart Jones, Jonathan Ahmet, Kelly Ayton, et al.
Leukemia|October 4, 2024
Synergistic effect of concurrent high molecular risk mutations and lower JAK2 mutant variant allele frequencies on prognosis in patients with myelofibrosis-insights from a multicenter studyYu-Hung Wang, Chao-Hung Wei, Chien-Chin Lin, et al.
Nature|October 4, 2019
Coordinated alterations in RNA splicing and epigenetic regulation drive leukaemogenesisAkihide Yoshimi, Kuan-Ting Lin, Daniel H Wiseman, et al.
Cell Stem Cell|August 15, 2023
Single-cell multi-omics defines the cell-type-specific impact of splicing aberrations in human hematopoietic clonal outgrowthsMariela Cortés-López, Paulina Chamely, Allegra G Hawkins, et al.
Pageof 16